Kashiwa
Japan
avelumab, JAVELIN Head and Neck 100, PD-L1, squamous cell carcinoma of the head and neck, immunotherapy, radiation, chemotherapy
Digital pathology, artificial intelligence, Screening, NTRK, TRK inhibitors